Kawasaki Disease During COVID-19 Pandemic in Korea - Data Were Added but Are Needed More.
作者信息
Jo Dae Sun
机构信息
Department of Pediatrics, Jeonbuk National University Medical School, Jeonju, Korea.
Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, Korea.
出版信息
J Korean Med Sci. 2022 May 23;37(20):e170. doi: 10.3346/jkms.2022.37.e170.
Abstract
摘要
相似文献
1
Kawasaki Disease During COVID-19 Pandemic in Korea - Data Were Added but Are Needed More.韩国新冠疫情期间的川崎病——数据有所增加，但仍需更多数据。
J Korean Med Sci. 2022 May 23;37(20):e170. doi: 10.3346/jkms.2022.37.e170.
2
Prevalence and characteristics of Kawasaki disease before and during the COVID-19 pandemic.新冠疫情之前及期间川崎病的患病率和特征
World J Pediatr. 2021 Apr;17(2):215-217. doi: 10.1007/s12519-021-00412-5. Epub 2021 Feb 6.
3
Kawasaki Disease During the SARS-CoV-2 Pandemic.新冠疫情期间的川崎病
Indian J Pediatr. 2022 Nov;89(11):1157. doi: 10.1007/s12098-022-04365-z. Epub 2022 Sep 15.
4
Novel coronavirus infection and Kawasaki disease.新型冠状病毒感染与川崎病。
J Matern Fetal Neonatal Med. 2022 Aug;35(16):3044-3048. doi: 10.1080/14767058.2020.1800633. Epub 2020 Jul 30.
5
Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea.新冠疫情时代非药物干预后川崎病发病率的下降：韩国一项全国性观察性研究
Circulation. 2021 Jun 22;143(25):2508-2510. doi: 10.1161/CIRCULATIONAHA.121.054785. Epub 2021 Jun 7.
6
The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children.新型冠状病毒（COVID-19）与儿童川崎病风险
J Formos Med Assoc. 2020 Nov;119(11):1713-1714. doi: 10.1016/j.jfma.2020.05.030. Epub 2020 May 23.
7
Severity predictors in pediatric SARS-CoV-2 and MIS-C.儿童新冠病毒（SARS-CoV-2）及儿童多系统炎症综合征（MIS-C）的严重程度预测指标
J Pediatr. 2021 May;232:307-310. doi: 10.1016/j.jpeds.2021.02.057.
8
Kawasaki disease or Kawasaki-like disease: Influence of SARS-CoV-2 infections in Japan.川崎病或川崎样疾病：日本SARS-CoV-2感染的影响
Acta Paediatr. 2021 Feb;110(2):600-601. doi: 10.1111/apa.15535. Epub 2020 Oct 13.
9
COVID-19 and Kawasaki syndrome: should we really be surprised?新冠病毒与川崎病：我们真的应该感到惊讶吗？
Cardiol Young. 2020 Jul;30(7):1059-1060. doi: 10.1017/S1047951120001432. Epub 2020 Jun 25.
10
Kawasaki disease before and during the COVID-19 pandemic: a single-center comparative study in Switzerland.川崎病在 COVID-19 大流行前后：瑞士单中心比较研究。
BMC Pediatr. 2024 Oct 8;24(1):637. doi: 10.1186/s12887-024-05115-0.
引用本文的文献
1
Comparison of Clinical Manifestations of Kawasaki Disease According to SARS-CoV-2 Antibody Positivity.比较 SARS-CoV-2 抗体阳性与阴性川崎病患儿的临床表现。
J Korean Med Sci. 2023 Jun 19;38(24):e181. doi: 10.3346/jkms.2023.38.e181.
本文引用的文献
1
Changes in the Clinical Characteristics of Kawasaki Disease After Coronavirus Disease (COVID-19) Pandemic: A Database Analysis.COVID-19 大流行后川崎病临床特征的变化：数据库分析。
J Korean Med Sci. 2022 May 23;37(20):e141. doi: 10.3346/jkms.2022.37.e141.
2
Changes in the Incidence of Intussusception and Infectious Diseases After the COVID-19 Pandemic in Korea.韩国 COVID-19 大流行后肠套叠和传染病发病率的变化。
J Korean Med Sci. 2022 Feb 28;37(8):e60. doi: 10.3346/jkms.2022.37.e60.
3
Impact of Social Distancing on Intussusception Incidence in Children.社交隔离对儿童肠套叠发病率的影响。
J Korean Med Sci. 2022 Jan 10;37(2):e16. doi: 10.3346/jkms.2022.37.e16.
4
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理：美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
Zotero 插件